中国医药
(600056)
| 流通市值：163.59亿 | | | 总市值：163.65亿 |
| 流通股本：14.95亿 | | | 总股本：14.96亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,999,554,381.83 | 2,769,756,319.52 | 4,356,499,260.42 | 2,706,629,673.57 |
| 交易性金融资产 | 128,730,210.41 | 128,730,210.41 | 128,730,210.41 | - |
| 应收票据及应收账款 | 14,964,260,471.64 | 14,841,460,587.84 | 13,563,661,134.43 | 15,801,408,852.22 |
| 其中：应收票据 | 203,592,190.41 | 537,392,004.84 | 543,977,467.35 | 445,529,351.94 |
| 应收账款 | 14,760,668,281.23 | 14,304,068,583 | 13,019,683,667.08 | 15,355,879,500.28 |
| 应收款项融资 | 348,003,755.81 | 234,112,430.04 | 387,121,445.84 | 253,766,809.94 |
| 预付款项 | 1,120,048,675.02 | 1,063,401,420.24 | 727,984,832.57 | 1,105,934,342.75 |
| 其他应收款合计 | 1,697,815,178.16 | 1,582,067,947.08 | 1,598,962,001.08 | 1,748,660,144.59 |
| 存货 | 6,248,545,517.99 | 5,769,273,940.01 | 6,285,067,620.81 | 6,830,209,470.71 |
| 合同资产 | 27,856,201.55 | 84,287,312.19 | 56,619,943.98 | 29,309,592.85 |
| 一年内到期的非流动资产 | - | 44,210,847.2 | 46,448,446.08 | 53,405,277.74 |
| 其他流动资产 | 287,456,574.65 | 270,847,841.76 | 263,229,137.28 | 349,593,832.61 |
| 流动资产合计 | 27,822,270,967.06 | 26,788,148,856.29 | 27,414,324,032.9 | 28,878,917,996.98 |
| 非流动资产: | | | | |
| 长期应收款 | 11,120,646.38 | 14,019,004.24 | 10,623,788.41 | 18,326,038.5 |
| 长期股权投资 | 2,722,004,968.26 | 2,709,421,496.51 | 2,693,259,296.51 | 2,684,276,717.03 |
| 其他权益工具投资 | 47,168,046.76 | 47,892,962.15 | 47,168,046.76 | 47,085,401.26 |
| 投资性房地产 | 90,782,571.34 | 91,807,660.57 | 94,627,563.46 | 88,082,460.82 |
| 固定资产 | 2,272,556,825.81 | 2,283,830,265.74 | 2,248,743,460.43 | 2,260,725,729.05 |
| 在建工程 | 208,363,658.86 | 201,915,499.24 | 257,610,059.01 | 236,704,579.8 |
| 使用权资产 | 259,848,011.23 | 281,931,199.75 | 302,784,180.61 | 293,569,750.42 |
| 无形资产 | 672,045,668.76 | 671,259,331.23 | 678,489,157.75 | 614,922,727.48 |
| 开发支出 | 495,495,305.48 | 485,688,685.8 | 476,017,072.6 | 530,291,755.8 |
| 商誉 | 996,062,765.04 | 996,062,765.04 | 996,062,765.04 | 1,123,822,084.62 |
| 长期待摊费用 | 143,422,322.27 | 147,407,867.8 | 152,476,078.22 | 156,051,716.46 |
| 递延所得税资产 | 707,518,233.54 | 711,448,406.67 | 693,428,913.03 | 675,571,807.74 |
| 其他非流动资产 | 263,284,547.6 | 260,221,851.02 | 259,711,597.54 | 269,527,854.39 |
| 非流动资产合计 | 8,889,673,571.33 | 8,902,906,995.76 | 8,911,001,979.37 | 8,998,958,623.37 |
| 资产总计 | 36,711,944,538.39 | 35,691,055,852.05 | 36,325,326,012.27 | 37,877,876,620.35 |
| 流动负债: | | | | |
| 短期借款 | 4,129,091,717.07 | 4,130,903,346.39 | 4,005,522,699.55 | 3,584,066,818.33 |
| 衍生金融负债 | - | - | 154,794.37 | - |
| 应付票据及应付账款 | 9,599,411,225.99 | 8,766,519,921.33 | 8,657,830,495.55 | 10,443,355,990.58 |
| 其中：应付票据 | 1,822,637,750.45 | 1,458,044,421.81 | 1,495,912,512 | 1,263,266,418.7 |
| 应付账款 | 7,776,773,475.54 | 7,308,475,499.52 | 7,161,917,983.55 | 9,180,089,571.88 |
| 预收款项 | 2,789,275.63 | 2,501,360.16 | 1,351,471.78 | 6,358,640.72 |
| 合同负债 | 1,016,590,847.39 | 1,145,083,584.96 | 1,087,220,446.99 | 1,239,677,056.4 |
| 应付职工薪酬 | 185,955,647.85 | 182,063,367.92 | 256,514,841.13 | 258,201,322.96 |
| 应交税费 | 199,914,071.07 | 199,216,880.06 | 204,227,833.11 | 132,509,208.14 |
| 其他应付款合计 | 3,062,119,549.7 | 2,532,377,049.31 | 2,829,066,088.73 | 3,473,041,559.38 |
| 应付股利 | 130,562,628.01 | 2,440,527.59 | 5,435,337.53 | 19,508,671.31 |
| 一年内到期的非流动负债 | 1,267,652,199.87 | 93,378,155.08 | 700,255,146.13 | 550,173,018.41 |
| 其他流动负债 | 189,965,873.55 | 171,714,473.17 | 260,149,802.9 | 224,748,238.51 |
| 流动负债合计 | 19,653,490,408.12 | 17,223,758,138.38 | 18,002,293,620.24 | 19,912,131,853.43 |
| 非流动负债: | | | | |
| 长期借款 | 719,800,000 | 1,894,256,829.3 | 1,553,356,829.3 | 1,643,856,829.3 |
| 租赁负债 | 201,883,162.05 | 207,444,786.04 | 187,914,681 | 235,187,992.1 |
| 长期应付款 | 1,883,675,795.65 | 1,889,671,029.18 | 2,126,159,509.38 | 1,899,394,225.31 |
| 长期应付职工薪酬 | 15,510,796.45 | 16,599,626.18 | 16,448,768.61 | 16,625,799.57 |
| 预计负债 | - | - | - | 1,672,226.55 |
| 递延收益 | 65,385,547 | 63,751,643.56 | 65,383,338.12 | 66,569,124.24 |
| 递延所得税负债 | 44,233,386.58 | 56,258,529.53 | 44,201,985.72 | 13,684,654.69 |
| 非流动负债合计 | 2,930,488,687.73 | 4,127,982,443.79 | 3,993,465,112.13 | 3,876,990,851.76 |
| 负债合计 | 22,583,979,095.85 | 21,351,740,582.17 | 21,995,758,732.37 | 23,789,122,705.19 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,495,879,748 | 1,495,879,748 | 1,495,879,748 | 1,495,879,748 |
| 资本公积 | 1,799,105,055.7 | 2,084,126,755.08 | 2,101,175,055.7 | 2,012,303,239.72 |
| 其他综合收益 | 3,720,973.91 | 1,977,145.84 | 1,092,168.55 | -2,069,120.46 |
| 盈余公积 | 630,553,833.6 | 613,257,225.23 | 630,553,833.6 | 603,726,551.38 |
| 未分配利润 | 7,794,316,201.7 | 7,792,539,328.46 | 7,803,931,077.54 | 7,547,371,404.8 |
| 归属于母公司股东权益合计 | 11,723,575,812.91 | 11,987,780,202.61 | 12,032,631,883.39 | 11,657,211,823.44 |
| 少数股东权益 | 2,404,389,629.63 | 2,351,535,067.27 | 2,296,935,396.51 | 2,431,542,091.72 |
| 股东权益合计 | 14,127,965,442.54 | 14,339,315,269.88 | 14,329,567,279.9 | 14,088,753,915.16 |
| 负债和股东权益合计 | 36,711,944,538.39 | 35,691,055,852.05 | 36,325,326,012.27 | 37,877,876,620.35 |
| 公告日期 | 2025-08-28 | 2025-04-30 | 2025-04-26 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |